unknown
Stage
About
HoneyBear Biosciences is a biotech company leveraging a proprietary site-specific antibody-drug conjugation platform, CoNectar®, to develop next-generation antibody-drug conjugates for global drug development.
Explore Honeybearbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.